Knowing Is Worth The Wait

Context
A cancer diagnosis triggers panic. Patients want to act immediately, yet treating without biomarker results leads to missed opportunities. The GCCA needed to disrupt this urgency. We had to convince a terrified audience, and their doctors, that waiting for test results isn't hesitation. It is the necessary precision and part of the treatment.
Approach
We anchored the visual strategy in "Illumination." Dark blue signifies the unknown, transitioning to bright blue as the brand’s orange dot blinks white to light up the answer. We scaled this concept from the Biomarker IQ Quiz and patient films to the ASCO GI booth and printed toolkits and more, creating a unified, cross-channel experience.
Client
Global CCA
Services
Campaign Strategy
Microsite
Social Media & Content Creation
Motion Graphics & Animation
Event Booth Design
Merchandise & Print Collateral

We represented the "unknown" of a diagnosis with a deep blue canvas. To navigate this obscurity, our motion language introduces "illumination". Pulsing the brand’s dot white to visualize biomarkers as lights in the dark, guiding users from anxiety to precision.

"Thank you for the amazing work you are doing
worldwide to ensure EVERYONE is getting tested
before treatment."
— John Park, PharmD
US Commercial Director, Amgen